Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice

다국어 초록 (Multilingual Abstract)

Curcumin (diferuloylmethane) is a yellow pigment present in the spice turmeric(Curcuma longa) that has been associated with antioxidant, anti-inflammatory, anticancer,antiviral, and antibacterial activities as indicated by over 6,000 citations. Inaddition, over one hundred clinical studies have been carried out with curcumin. Oneof the major problems with curcumin is perceived to be the bioavailability. Howcurcumin should be delivered in vivo, how bioavailable is it, how well curcumin isabsorbed and how it is metabolized, is the focus of this review. Various formulationsof curcumin that are currently available are also discussed.

참고문헌 (Reference)

1 Aggarwal S, "[DLys(6)]-luteinizing hormone releasing hormone-curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo" 129 : 1611-1623, 2011

2 Dandekar P, "Toxicological evaluation of pH-sensitive nanoparticles of curcumin : acute, sub-acute and genotoxicity studies" 48 : 2073-2089, 2010

3 Lopez-Jornet P, "Topical curcumin for the healing of carbon dioxide laser skin wounds in mice" 29 : 809-814, 2011

4 Suresh D, "Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats" 131 : 682-691, 2010

5 Gupta SC, "Therapeutic roles of curcumin : lessons learned from clinical trials" 15 : 195-218, 2013

6 Lin YC, "Therapeutic efficacy evaluation of curcumin on human oral squamous cell carcinoma xenograft using multimodalities of molecular imaging" 38 : 343-358, 2010

7 Holder GM, "The metabolism and excretion of curcumin(1, 7-bis-(4-hydroxy-3-methoxyphenyl)-1, 6-heptadiene-3, 5-dione)in the rat" 8 : 761-768, 1978

8 Singh R, "The influence of Pluronics(R)on dark cytotoxicity, photocytotoxicity, localization and uptake of curcumin in cancer cells : studies of curcumin and curcuminoids XLIX" 12 : 559-575, 2013

9 Lai CS, "Tetrahydrocurcumin is more effective than curcumin in preventing azoxymethane-induced colon carcinogenesis" 55 : 1819-1828, 2011

10 Aggarwal BB, "Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals" 30 : 173-199, 2010

11 Li C, "Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin" 7 : 5995-6002, 2012

12 Gupta SC, "Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals" 29 : 405-434, 2010

13 Rahman I, "Regulation of inflammation and redox signaling by dietary polyphenols" 72 : 1439-1452, 2006

14 Marczylo TH, "Rapid analysis of curcumin and curcumin metabolites in rat biomatrices using a novel ultraperformance liquid chromatography(UPLC) method" 57 : 797-803, 2009

15 Nair KL, "Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier" 425 : 44-52, 2012

16 Nemmar A, "Protective effect of curcumin on pulmonary and cardiovascular effects induced by repeated exposure to diesel exhaust particles in mice" 7 : e39554-, 2012

17 Gao Y, "Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer" 36 : 1225-1234, 2010

18 Feng R, "Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles" 7 : 4089-4098, 2012

19 Kim TH, "Preparation and characterization of water-soluble albuminbound curcumin nanoparticles with improved antitumor activity" 403 : 285-291, 2011

20 Pandelidou M, "Preparation and characterization of lyophilised egg PC liposomes incorporating curcumin and evaluation of its activity against colorectal cancer cell lines" 11 : 1259-1266, 2011

21 Gao Y, "Preparation and characterization of intravenously injectable curcumin nanosuspension" 18 : 131-142, 2011

22 Moorthi C, "Preparation and characterization of curcumin-piperine dual drug loaded nanoparticles" 2 : 841-848, 2012

23 Zhang L, "Physical characterization and cellular uptake of propylene glycol liposomes in vitro" 2012

24 Sharma RA, "Phase I clinical trial of oral curcumin : biomarkers of systemic activity and compliance" 10 : 6847-6854, 2004

25 Cheng AL, "Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions" 21 : 2895-2900, 2001

26 Khalil NM, "Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats" 101 : 353-360, 2013

27 Sharma RA, "Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer" 7 : 1894-1900, 2001

28 Xie X, "PLGA nanoparticles improve the oral bioavailability of curcumin in rats : characterizations and mechanisms" 59 : 9280-9289, 2011

29 Yang KY, "Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS" 853 : 183-189, 2007

30 Asai A, "Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma" 67 : 2785-2793, 2000

31 Pawar YB, "Novel lipid based oral formulation of curcumin : development and optimization by design of experiments approach" 436 : 617-623, 2012

32 Alam S, "Novel dipeptide nanoparticles for effective curcumin delivery" 7 : 4207-4222, 2012

33 Sun Y, "Neuroprotection and sensorimotor functional improvement by curcumin after intracerebral hemorrhage in mice" 28 : 2513-2521, 2011

34 Ghosh D, "Nanocapsulated curcumin : oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat" 195 : 206-214, 2012

35 Chen H, "N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin" 22 : 100-109, 2012

36 Gupta SC, "Multitargeting by curcumin as revealed by molecular interaction studies" 28 : 1937-1955, 2011

37 Rachmawati H, "Molecular inclusion complex of curcumin-beta-cyclodextrin nanoparticle to enhance curcumin skin permeability from hydrophilic matrix gel" 14 : 1303-1312, 2013

38 Ravindranath V, "Metabolism of curcumin--studies with [3H]curcumin" 22 : 337-344, 1981

39 Wang D, "Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKTindependent pathway" 14 : 6228-6236, 2008

40 Agarwal NB, "Liposomal formulation of curcumin attenuates seizures in different experimental models of epilepsy in mice" 27 : 169-172, 2013

41 Basnet P, "Liposomal delivery system enhances anti-inflammatory properties of curcumin" 101 : 598-609, 2012

42 Subhashini, "Intranasal curcumin and its evaluation in murine model of asthma" 17 : 733-743, 2013

43 Sasaki H, "Innovative preparation of curcumin for improved oral bioavailability" 34 : 660-665, 2011

44 Shahani K, "Injectable sustained release microparticles of curcumin: a new concept for cancer chemoprevention" 70 : 4443-4452, 2010

45 Khopde SM, "Inhibition of radiation-induced lipid peroxidation by tetrahydrocurcumin : possible mechanisms by pulse radiolysis" 64 : 503-509, 2000

46 Shoba G, "Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers" 64 : 353-356, 1998

47 Saengkrit N, "Influence of curcumin-loaded cationic liposome on anticancer activity for cervical cancer therapy" 114 : 349-356, 2014

48 Gong C, "Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles" 34 : 1413-1432, 2013

49 Cheng KK, "Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer's disease Tg2576 mice" 15 : 324-336, 2013

50 Shahani K, "Highly loaded, sustained-release microparticles of curcumin for chemoprevention" 100 : 2599-2609, 2011

51 Liu CW, "Graphene-based anticancer nanosystem and its biosafety evaluation using a zebrafish model" 14 : 358-366, 2013

52 Mukerjee A, "Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy" 29 : 3867-3875, 2009

53 Li H, "Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro" 2013

54 Wang S, "Formulation and evaluation of microemulsion-based in situ ion-sensitive gelling systems for intranasal administration of curcumin" 20 : 831-840, 2012

55 Hegge AB, "Formulation and bacterial phototoxicity of curcumin loaded alginate foams for wound treatment applications : studies on curcumin and curcuminoides XLII" 100 : 174-185, 2011

56 Yallapu MM, "Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells" 351 : 19-29, 2010

57 Takahashi M, "Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin" 57 : 9141-9146, 2009

58 Thangapazham RL, "Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells" 32 : 1119-1123, 2008

59 Reuter S, "Epigenetic changes induced by curcumin and other natural compounds" 6 : 93-108, 2011

60 Sidhu GS, "Enhancement of wound healing by curcumin in animals" 6 : 167-177, 1998

61 Zhongfa L, "Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice" 69 : 679-689, 2012

62 Chen X, "Enhanced brain targeting of curcumin by intranasal administration of a thermosensitive poloxamer hydrogel" 65 : 807-816, 2013

63 Marrache S, "Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics" 109 : 16288-16293, 2012

64 Chang MT, "Elevating bioavailability of curcumin via encapsulation with a novel formulation of artificial oil bodies" 61 : 9666-9671, 2013

65 Tsai YM, "Effects of polymer molecular weight on relative oral bioavailability of curcumin" 7 : 2957-2966, 2012

66 Takahashi M, "Effects of curcumin supplementation on exercise-induced oxidative stress in humans" 2013

67 Yoysungnoen P, "Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice" 34 : 109-115, 2006

68 Huang MT, "Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz[a]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice" 19 : 1697-1700, 1998

69 John MK, "Development and pharmacokinetic evaluation of a curcumin co-solvent formulation" 33 : 4285-4291, 2013

70 Garcea G, "Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration" 90 : 1011-1015, 2004

71 Pandey MK, "Design, synthesis and evaluation of novel PEGylated curcumin analogs as potent Nrf2 activators in human bronchial epithelial cells" 43 : 16-24, 2011

72 Anand P, "Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo" 79 : 330-338, 2010

73 Yallapu MM, "Design of curcumin loaded cellulose nanoparticles for prostate cancer" 13 : 120-128, 2012

74 Guzman-Villanueva D, "Design and in vitro evaluation of a new nanomicroparticulate system for enhanced aqueous-phase solubility of curcumin" 2013 : 724763-, 2013

75 Chen CY, "Cytotoxic activity and cell cycle analysis of hexahydrocurcumin on SW 480 human colorectal cancer cells" 6 : 1671-1672, 2011

76 Agashe H, "Cyclodextrinmediated entrapment of curcuminoid 4-[3, 5-bis(2-chlorobenzylidene-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats" 84 : 329-337, 2011

77 Yadav VR, "Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake" 80 : 1021-1032, 2010

78 Aditya NP, "Curcuminoids-loaded liposomes in combination with arteether protects against Plasmodium berghei infection in mice" 131 : 292-299, 2012

79 Nishiyama T, "Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice" 53 : 959-963, 2005

80 Sun J, "Curcuminloaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability" 111C : 367-375, 2013

81 Dovigo LN, "Curcumin-mediated photodynamic inactivation of Candida albicans in a murine model of oral candidiasis" 51 : 243-251, 2013

82 Peng SF, "Curcumin-loaded nanoparticles enhance apoptotic cell death of U2OS human osteosarcoma cells through the Akt-Bad signaling pathway" 44 : 238-246, 2014

83 Dhule SS, "Curcumin-loaded gamma-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma" 8 : 440-451, 2012

84 Gou M, "Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo" 3 : 1558-1567, 2011

85 Gandapu U, "Curcumin-loaded apotransferrin nanoparticles provide efficient cellular uptake and effectively inhibit HIV-1 replication in vitro" 6 : e23388-, 2011

86 Mourtas S, "Curcumin-decorated nanoliposomes with very high affinity for amyloid-beta1-42 peptide" 32 : 1635-1645, 2011

87 Goel A, "Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs" 62 : 919-930, 2010

88 Sharma S, "Curcumin, the active principle of turmeric(Curcuma longa), ameliorates diabetic nephropathy in rats" 33 : 940-945, 2006

89 Tirkey N, "Curcumin, a diferuloylmethane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidneys" 5 : 15-, 2005

90 Gupta SC, "Curcumin, a component of turmeric : from farm to pharmacy" 39 : 2-13, 2013

91 Du WZ, "Curcumin suppresses malignant glioma cells growth and induces apoptosis by inhibition of SHH/GLI1 signaling pathway in vitro and vivo" 19 : 926-936, 2013

92 LoTempio MM, "Curcumin suppresses growth of head and neck squamous cell carcinoma" 11 (11): 6994-7002, 2005

93 Liu L, "Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis" 443 : 175-182, 2013

94 Kumar SS, "Curcumin loaded poly(2-hydroxyethyl methacrylate)nanoparticles from gelled ionic liquid : in vitro cytotoxicity and anti-cancer activity in SKOV-3 cells" 51 : 34-44, 2014

95 Kumar A, "Curcumin loaded nano globules for solubility enhancement : preparation, characterization and ex vivo release study" 12 : 8293-8302, 2012

96 Sun J, "Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice" 8 : e67078-, 2013

97 Smith MR, "Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury" 298 : L616-L625, 2010

98 Clark CA, "Curcumin inhibits carcinogen and nicotine-induced mammalian target of rapamycin pathway activation in head and neck squamous cell carcinoma" 3 : 1586-1595, 2010

99 Phillips J, "Curcumin inhibits UV radiation-induced skin cancer in SKH-1 mice" 148 : 797-803, 2013

100 Wang C, "Curcumin inhibits HMGB1 releasing and attenuates concanavalin A-induced hepatitis in mice" 697 : 152-157, 2012

101 Tu SP, "Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth" 5 : 205-215, 2012

102 Pal A, "Curcumin glucuronides : assessing the proliferative activity against human cell lines" 22 : 435-439, 2014

103 Ryan JL, "Curcumin for radiation dermatitis : a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients" 180 : 34-43, 2013

104 Sidhu GS, "Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice" 7 : 362-374, 1999

105 Cheng KW, "Curcumin enhances the lung cancer chemopreventive efficacy of phospho-sulindac by improving its pharmacokinetics" 43 : 895-902, 2013

106 Duarte VM, "Curcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKKbeta protein of the NFkappaB pathway" 9 : 2665-2675, 2010

107 Patzko A, "Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice" 135 (135): 3551-3566,

108 Gangwar RK, "Curcumin conjugated silica nanoparticles for improving bioavailability and its anticancer applications" 61 : 9632-9637, 2013

109 Murakami A, "Curcumin combined with turmerones, essential oil components of turmeric, abolishes inflammation-associated mouse colon carcinogenesis" 39 : 221-232, 2013

110 Chowdhury R, "Curcumin attenuation of lipopolysaccharide induced cardiac hypertrophy in rodents" 2013 : 539305-, 2013

111 Kawanishi N, "Curcumin attenuates oxidative stress following downhill running-induced muscle damage" 441 : 573-578, 2013

112 Oh SW, "Curcumin attenuates allergic airway inflammation and hyperresponsiveness in mice through NF-kappaB inhibition" 136 : 414-421, 2011

113 He HJ, "Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice" 3 : 94-104, 2012

114 Okada K, "Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice" 131 : 2090-2095, 2001

115 Ryu EK, "Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for β-amyloid plaque imaging" 49 : 6111-6119, 2006

116 Suwannateep N, "Comparison of two encapsulated curcumin particular systems contained in different formulations with regard to in vitro skin penetration" 19 : 1-9, 2013

117 Pan MH, "Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages" 60 : 1665-1676, 2000

118 Somparn P, "Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives" 30 : 74-78, 2007

119 Misra R, "Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells" 8 : 852-866, 2011

120 Perkins S, "Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis" 11 : 535-540, 2002

121 Ireson C, "Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production" 61 : 1058-1064, 2001

122 Pan MH, "Biotransformation of curcumin through reduction and glucuronidation in mice" 27 : 486-494, 1999

123 Rejinold NS, "Biocompatible, biodegradable and thermo-sensitive chitosan-g-poly(N-isopropylacrylamide)nanocarrier for curcumin drug delivery" 49 : 161-172, 2011

124 Anand P, "Bioavailability of curcumin : problems and promises" 4 : 807-818, 2007

125 Isacchi B, "Artemisinin and artemisinin plus curcumin liposomal formulations : enhanced antimalarial efficacy against Plasmodium berghei-infected mice" 80 : 528-534, 2012

126 Sharma V, "Antioxidant potential of curcumin against oxidative insult induced by pentylenetetrazol in epileptic rats" 32 : 227-232, 2010

127 Sharma OP, "Antioxidant activity of curcumin and related compounds" 25 : 1811-1812, 1976

128 Negi PS, "Antibacterial activity of turmeric oil : a byproduct from curcumin manufacture" 47 : 4297-4300, 1999

129 Park JH, "Amphiphilic peptide carrier for the combined delivery of curcumin and plasmid DNA into the lungs" 33 : 6542-6550, 2012

130 Ravindranath V, "Absorption and tissue distribution of curcumin in rats" 16 : 259-265, 1980

131 Shi HS, "A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation" 7 : 2601-2611, 2012

132 Wahlstrom B, "A study on the fate of curcumin in the rat" 43 : 86-92, 1978

133 Lin YL, "A Lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells" 8 : 318-327, 2012